508 related articles for article (PubMed ID: 35171030)
21. Phage vB_Ec_ZCEC14 to treat antibiotic-resistant Escherichia coli isolated from urinary tract infections.
Ismael NM; Azzam M; Abdelmoteleb M; El-Shibiny A
Virol J; 2024 Feb; 21(1):44. PubMed ID: 38365702
[TBL] [Abstract][Full Text] [Related]
22. Two novel phages, Klebsiella phage GADU21 and Escherichia phage GADU22, from the urine samples of patients with urinary tract infection.
Salih Doğan H; Karaynir A; Yilmaz Üİ; Başgöz BB; Hoşbul T; Bozdoğan B
Virus Genes; 2024 Apr; 60(2):208-221. PubMed ID: 38238612
[TBL] [Abstract][Full Text] [Related]
23. Multiple antibiotic resistances and virulence markers of uropathogenic Escherichia coli from Mexico.
Paniagua-Contreras GL; Monroy-Pérez E; Bautista A; Reyes R; Vicente A; Vaca-Paniagua F; Díaz CE; Martínez S; Domínguez P; García LR; Uribe-García A; Vaca S
Pathog Glob Health; 2018 Dec; 112(8):415-420. PubMed ID: 30433859
[TBL] [Abstract][Full Text] [Related]
24. Effects of single and combined use of bacteriophages and antibiotics to inactivate Escherichia coli.
Valério N; Oliveira C; Jesus V; Branco T; Pereira C; Moreirinha C; Almeida A
Virus Res; 2017 Aug; 240():8-17. PubMed ID: 28746884
[TBL] [Abstract][Full Text] [Related]
25. Study of class 1 integrons and plasmid profile among multiple drug resistant uropathogenic Escherichia coli.
Javed S; Mirani ZA; Pirzada ZA
Pak J Pharm Sci; 2020 Nov; 33(6):2643-2649. PubMed ID: 33867342
[TBL] [Abstract][Full Text] [Related]
26. Characterising the biology of novel lytic bacteriophages infecting multidrug resistant Klebsiella pneumoniae.
Kęsik-Szeloch A; Drulis-Kawa Z; Weber-Dąbrowska B; Kassner J; Majkowska-Skrobek G; Augustyniak D; Lusiak-Szelachowska M; Zaczek M; Górski A; Kropinski AM
Virol J; 2013 Mar; 10():100. PubMed ID: 23537199
[TBL] [Abstract][Full Text] [Related]
27. Alternative treatment approaches of urinary tract infections caused by uropathogenic Escherichia coli strains.
Zalewska-Piątek BM; Piątek RJ
Acta Biochim Pol; 2019 May; 66(2):129-138. PubMed ID: 31136644
[TBL] [Abstract][Full Text] [Related]
28. Escherichia coli clonal group A among uropathogenic infections in Mexico City.
Manjarrez-Hernandez A; Molina-López J; Gavilanes-Parra S; Hernandez-Castro R
J Med Microbiol; 2016 Dec; 65(12):1438-1444. PubMed ID: 27902433
[TBL] [Abstract][Full Text] [Related]
29. Genome Analysis and Antibiofilm Activity of Phage 590B against Multidrug-Resistant and Extensively Drug-Resistant Uropathogenic
Chaudhary N; Maurya RK; Singh D; Mohan B; Taneja N
Pathogens; 2022 Nov; 11(12):. PubMed ID: 36558782
[TBL] [Abstract][Full Text] [Related]
30. Antibiotic resistance, virulence factors and genotyping of Uropathogenic
Raeispour M; Ranjbar R
Antimicrob Resist Infect Control; 2018; 7():118. PubMed ID: 30305891
[TBL] [Abstract][Full Text] [Related]
31. Identification of novel bacteriophage vB_EcoP-EG1 with lytic activity against planktonic and biofilm forms of uropathogenic Escherichia coli.
Gu Y; Xu Y; Xu J; Yu X; Huang X; Liu G; Liu X
Appl Microbiol Biotechnol; 2019 Jan; 103(1):315-326. PubMed ID: 30397766
[TBL] [Abstract][Full Text] [Related]
32. Bacteriophage activity against and characterisation of avian pathogenic Escherichia coli isolated from colibacillosis cases in Uganda.
Kazibwe G; Katami P; Alinaitwe R; Alafi S; Nanteza A; Nakavuma JL
PLoS One; 2020; 15(12):e0239107. PubMed ID: 33320859
[TBL] [Abstract][Full Text] [Related]
33. Significant association between genes encoding virulence factors with antibiotic resistance and phylogenetic groups in community acquired uropathogenic Escherichia coli isolates.
Yazdanpour Z; Tadjrobehkar O; Shahkhah M
BMC Microbiol; 2020 Aug; 20(1):241. PubMed ID: 32758126
[TBL] [Abstract][Full Text] [Related]
34. Previous Antibiotic Exposure Reshapes the Population Structure of Infecting Uropathogenic Escherichia coli Strains by Selecting for Antibiotic Resistance over Urovirulence.
Ballash GA; Diaz-Campos D; van Balen JC; Mollenkopf DF; Wittum TE
Microbiol Spectr; 2023 Aug; 11(4):e0524222. PubMed ID: 37338386
[TBL] [Abstract][Full Text] [Related]
35. Bacterial characteristics of importance for recurrent urinary tract infections caused by Escherichia coli.
Ejrnæs K
Dan Med Bull; 2011 Apr; 58(4):B4187. PubMed ID: 21466767
[TBL] [Abstract][Full Text] [Related]
36. Bacteriophage therapy for inhibition of multi drug-resistant uropathogenic bacteria: a narrative review.
Chegini Z; Khoshbayan A; Vesal S; Moradabadi A; Hashemi A; Shariati A
Ann Clin Microbiol Antimicrob; 2021 Apr; 20(1):30. PubMed ID: 33902597
[TBL] [Abstract][Full Text] [Related]
37. Characterization, genome analysis and in vitro activity of a novel phage vB_EcoA_RDN8.1 active against multi-drug resistant and extensively drug-resistant biofilm-forming uropathogenic Escherichia coli isolates, India.
Chaudhary N; Mohan B; Mavuduru RS; Kumar Y; Taneja N
J Appl Microbiol; 2022 Apr; 132(4):3387-3404. PubMed ID: 34989075
[TBL] [Abstract][Full Text] [Related]
38. Characterization of Escherichia coli isolates from hospital inpatients or outpatients with urinary tract infection.
Toval F; Köhler CD; Vogel U; Wagenlehner F; Mellmann A; Fruth A; Schmidt MA; Karch H; Bielaszewska M; Dobrindt U
J Clin Microbiol; 2014 Feb; 52(2):407-18. PubMed ID: 24478469
[TBL] [Abstract][Full Text] [Related]
39. Bacteriophage isolated from non-target bacteria demonstrates broad host range infectivity against multidrug-resistant bacteria.
Ngiam L; Schembri MA; Weynberg K; Guo J
Environ Microbiol; 2021 Sep; 23(9):5569-5586. PubMed ID: 34390602
[TBL] [Abstract][Full Text] [Related]
40. Characterization and in vitro activity of a lytic phage RDN37 isolated from community sewage water active against MDR Uropathogenic E. coli.
Chaudhary N; Narayan C; Mohan B; Taneja N
Indian J Med Microbiol; 2021 Jul; 39(3):343-348. PubMed ID: 33994226
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
